Gemina Laboratories Ltd. GLABF

GLABF Company Overview

Gemina Laboratories Ltd. is a biotechnology and diagnostics company focused on the development, manufacturing, and commercialization of rapid, point‑of‑care diagnostic tests. The company operates within the medical diagnostics and biotechnology industries, with a primary emphasis on infectious disease detection. Its core product line centers on rapid antigen testing designed for decentralized settings such as workplaces, schools, healthcare facilities, and at‑home use.

The company is best known for its Rapid Response™ branded diagnostic tests, including saliva‑based COVID‑19 antigen tests, which differentiate the company through non‑invasive sample collection and rapid results. Gemina Laboratories Ltd. was founded in Canada and advanced from an early‑stage diagnostics developer into a commercial‑stage company during the COVID‑19 pandemic, leveraging public health demand and regulatory authorizations to bring products to market. Its evolution has been closely tied to infectious disease response and public health testing needs.